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Abstract 
Objectives: Exoskeletons are electromechanical devices that are worn by a human operator and 
designed to increase the physical performance of the wearer. Exoskeleton technology has developed 
significantly over the past decade as a result of improvements in robotics technology and mechatronics 
technology. However the existing generation of exoskeletons have significant limitations with respect 
to their affordability, size, weight, speed and efficiency. These limitations may reduce the functional 
usefulness of the devices for individuals with neurological impairment, a population who are most likely 
to benefit from the technology. 
 
The aim of this study is to identify existing literature that reports user perspectives of exoskeleton 
technology in order to inform the design and technical development of future wearable assistive 
materials.   
 
Methods: An in depth literature search was conducted across several healthcare related online 
databases. 
 
Results: 912 articles were identified, 893 were eliminated based on a review of their abstracts. Seven 
further articles were identified from references cited in the 19 articles fully reviewed. No published 
studies that consider the user’s perspective of exoskeleton technology were identified. However nine 
articles document the importance of user involvement in the design of assistive technology.  Assistive 
technology being any item, piece of equipment, software or product system that is used to increase, 
maintain, or improve the functional capabilities of individuals with disabilities (1). 
  
Conclusions: Evidence identified across a wider spectrum of literature relating to assistive technology 
and disability suggests the value of involving end users in the design of assistive technology to ensure 
their often-complex needs are met. Therefore, further research is needed to identify the aspirations and 
concerns of potential users of exoskeleton technology in order to inform the design and technical 
development of this innovative technology. 
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Introduction 
Exoskeletons are electromechanical devices that are worn by a human operator and designed to 
increase the physical performance of the wearer (2). Exoskeleton technology has developed 
significantly over the past decade as a result of improvements in robotics technology and mechatronics 
technology (3). Exoskeletons produced by Ekso Bionics Holdings (EKSOTM) in the USA, Rex Bionics 
PLC (REX®) in New Zealand (4), ReWalk Robotics (ReWalkTM) in Israel (5) and Parker Hannifin Corp 
(Indego® ) have already reached the commercial market internationally (6). In addition a system 
developed by Cyberdene (the hybrid assisted limb - HAL®) in Japan received a global safety certification 
in 2013 and has subsequently received an EC Certificate of Conformity in Germany, although is yet to 
be distributed widely within Europe (7).  
 
All of the currently available commercial systems have different design specifications in terms of overall 
configuration, weight, battery life, cost, adjustability and functionality (see table 1), but the overall aim 
of each system is to enable individuals who have been paralysed by neurological dysfunction to stand 
up and walk. 
 
There have been recent reports in the media, which sensationally refer to the current exoskeleton 
systems as “extraordinary robotic suits that enable those with paralysis to stand and walk” (8, 9). Indeed 
for some individuals with neurological impairment, these exoskeletons will provide their first opportunity 
to be mobile without their wheelchair. However there are also opposing accounts on social media, 
written by wheelchair users who do not consider current exoskeletons to be a satisfactory alternative to 
the independence afforded to them by their wheelchairs. For example, Nicholson (10)states “My 
wheelchair is a very capable tool and to be honest, the last thing I want is to be strapped to a District 9-
esque robot and become a puppet in some corporations half-baked execution of an obsession with 
making the non-walkers walk again”. 
 
Despite their impressive functional capabilities, the existing generation of exoskeletons have significant 
limitations with respect to their affordability, size, weight, speed and efficiency (3, 11, 12). The 
exoskeletons available within the United Kingdom to date weigh between 23 Kg to 38.5 Kg (4, 13) Whilst 
the user physically carries none of the weight of the device whilst standing and walking (because the 
device fully supports the user’s body weight in addition to its own weight), they are heavy and 
cumbersome pieces of equipment to maneuver when trying to put on and take off, transport and store. 
 
Furthermore, walking speed is markedly reduced when wearing an exoskeleton as compared to normal 
walking speed in an able-bodied adult. Velocity of gait is defined as the average horizontal speed of the 
body measured over one or more strides (14, 15). Bohannon (16) published normative values for 
comfortable and maximal gait speeds based on normative data from 230 healthy individuals.  
Comfortable gait speed for young adults in their 20s is cited as 1.39 m/sec (males) and 1.40 m/sec 
(females), whilst for those in their 70s as 1.33 m/sec (males) and 1.27 m/sec (females).  In contrast, 
walking speeds for those with spinal cord injury who have been trained to walk using the  ReWalkTM 
exoskeleton are reported to range from 0.03 to 0.5 m/sec (6, 17).  Consequently whilst the exoskeleton 
may restore an individual’s ability to walk it does not yet do so at a speed that is commensurate with 
ambulation being a functional component of mobility for those with neurological impairment.   Indeed 
there is evidence to suggest that walking within an exoskeleton is slower than mobilising in either a 
manual or powered wheelchair.  Karmarkar (18) report an average speed of manual wheelchair 
propulsion of 0.64 m/s and an average speed of powered wheelchair mobility of 0.7m/s in adults aged 
50 years or older whilst using their wheelchairs in a community setting.   
 
These limitations reduce the access to and hence the functional usefulness of these devices for 
individuals with neurological impairment. Future devices are likely to harness emerging innovative 
technology such as 3D printing to develop bespoke, lightweight devices based on individual body size 
and shape (11, 12). The development of a device, which is functionally useful, safe and imperceptible 
to all but the user, is therefore likely to be the ultimate goal in the design of exoskeleton technology.  
A recent Wintergreen research report states that the rehabilitation robot market will grow from $43.3 
million to $1.8 billion by 2020 (15).  The lucrative potential of this technology however should not 
overshadow the need for the technology to be accessible and useful to the end user.   
 
Evidence that considers the development of more established and accessible assistive technology such 
as functional electrical stimulation (FES), advocates user involvement in the design process in order to 
ensure appropriate usability of the end product within everyday life (19, 20). McMillen and Söderberg 
(21) suggest that assistive technology may only be accepted by a person with disability if they see the 
device as useful for their own purposes. Whilst others (22-24) advocate that people with disability act 
as consultants in the development process of assistive technology, to provide valuable insight, ensuring 
that devices developed provide end users with worthwhile gains in independence and quality of life. 
  
The authors are part of a team at University College London (UCL) who, with a grant from the 
Engineering and Physical Science Research Council (EPSCR), seek to develop a wearable assistive 
material for use in exoskeleton technology. Thus the current study aims to identify and review existing 
literature that reports user perspectives of exoskeleton technology in order to inform the design and 
technical development of future devices. 
 
Methods 
A literature search was conducted across several healthcare related online databases including 
Pubmed; Scopus; The Cochrane Library; Medline and Cinahl. The search terms exoskeleton, robot or 
technology were combined with the terms user perspectives, user experiences or qualitative using 
Boolean operators (see table 2). These terms were then further combined with the terms rehabilitation 
and spinal cord injury, or neurological, or stroke. Terms were truncated to capture all possible 
derivatives of a key word. The searches were limited to published articles, written in English. No year 
restriction was entered. Articles found were then reviewed, duplicates deleted and references cited 
reviewed to determine if any other articles were relevant.  
 
 
Results 
A total of 912 articles (see table 2) were identified using the search terms, of which 893 were eliminated 
based on a review of their abstracts. The remaining 19 articles were reviewed in full. A further seven 
articles were identified from references cited in those articles. Of the articles selected for review, no 
studies were identified that specifically consider users’ perspectives of exoskeleton technology. 
However nine articles document the importance of user involvement in the design of assistive 
technology (Figure 1). 
 
Discussion 
Within the literature there are examples of different prototype exoskeletons that have been developed 
for use during rehabilitation of individuals with neurological impairment. A number of studies use 
therapeutic outcome measures to determine the efficacy of exoskeleton technology as compared to 
standard rehabilitation (17, 25, 26).  Other studies describe the development of specific design features 
of exoskeletons to augment or replace functional movement in individuals with neurological impairment 
(17, 27-29). However, to date there have been no published studies that consider the user’s perspective 
of exoskeleton technology. This is somewhat unsurprising given that it is relatively novel technology. 
Indeed in the United Kingdom exoskeletons are currently only available for individuals to trial within a 
handful of specialist private clinics and one of the eleven national spinal cord injury centres. 
Consequently only a small number of users have had the opportunity to use the technology, with very 
few individuals having their own exoskeleton device. 
 
However, evidence identified across a wide spectrum of literature relating to more established assistive 
technology and its use by those with neurological disability suggests the value of involving end users 
in technology design to ensure their often-complex needs are met (11, 22, 30-33). In fact the importance 
of user involvement in design of novel technologies has been stressed in many technologies including 
crisis response (34) and technologies for children (35, 36) and the elderly (37, 38).   
 
Within the novel area of exoskeleton development there are no published examples of the integration 
of users within the design process. Nevertheless there is evidence from related studies that suggests 
such integration is beneficial and therefore might be advocated. 
 
Kilgore, Scherer (22) considered consumers priorities for the development of neuroprostheses to 
support standing and ambulation in individuals following spinal cord injury. Key themes and priorities 
identified by their participants with respect to this specific technology were independence, ease of 
movement, ease of control and being able to “do what you did before the injury”. Exoskeletons are 
different to neuroprostheses in that they provide structural support and automated movement driven by 
motors and actuators rather than initiating muscular contraction in paralysed muscle with electrical 
stimulation. Nevertheless, the functional outcomes for both different types of technology are similar in 
that they relate to restoration of standing and walking following SCI. Consequently it could be 
hypothesised that similar priorities might be identified by potential users of exoskeleton technology as 
those identified by Kilgore, Scherer (22).  However such assumptions can only be hypothetical at this 
time given the lack of publications in user perspectives of exoskeleton technology to date. 
 
Lane, Usiak (30) state that capturing the wants and needs of the end user is a common practice in 
consumer product marketing and in the medical device design process but is a practice not widely 
applied to assistive technology. Assistive technology abandonment by end users is a well-documented 
phenomenon (39-42) and underlies the emerging awareness that individuals with disability should be 
involved in the development of assistive technology relevant to their needs (11). 
 
Shah and Robinson (32) identify that the main benefits of user involvement with respect to medical 
device technology development and evaluation are increased access to user needs, experiences and 
ideas; improvements in medical device design and user interfaces; and an increase in the functionality, 
usability and quality of the devices. The authors also identified barriers to user participation, which relate 
to the time and cost associated with involving them in the design process. However they conclude that 
despite limited resources user involvement is essential in the development and evaluation of medical 
device technology.  
 
Pape, Kim (43) suggest that the successful integration of assistive technology into daily living requires 
potential device users to explore the meanings they assign to specific devices; their expectations of 
assistive technology; the anticipated social costs and the degree to which their disability defines their 
identity. All of these considerations could be usefully explored with respect to exoskeleton technology 
in those with neurological impairment. Some individuals might view exoskeleton technology as a means 
to restore their ability to walk, with the expectation that they will be able to resume normal functional 
ambulation in daily activities. As such the anticipated impact on social participation and quality of life is 
likely to redefine their perception of self. However for others the technology may not meet their 
aspirations with respect to functional ambulation, for example due to speed, whilst the appearance of 
the device in situ might lead them to feel more conspicuous with respect to their disability. Brown-Triolo, 
Roach (23) in their study looking at consumer perspectives on mobility relating to neuroprosthesis 
design, report that individuals with SCI seem ready to disregard anything that will add to stigma, 
regardless of how effective it is. Therefore, only by seeking an understanding of potential stigma 
associated with the use of exoskeleton technology will designers be able to develop products that 
mitigate these concerns. 
 
Kiesler and Hinds (44) suggest that technical advances with respect to assistive technology have up 
until now dominated the published literature and argue that the fundamentals of robotic design need 
also to consider psychological and social factors. Certainly this review found a disproportionate volume 
of literature that reports design specifications of exoskeleton systems as compared to the absence of 
literature that considers user perspectives of the technology. 
 
Bates, Spencer (45) report the possibility of intense emotional responses to the introduction of 
wheelchairs and other assistive devices into a person’s life following the onset of acquired disability. It 
is likely that similar and extreme emotional responses might be expected when an individual is 
introduced to exoskeleton technology. The responses may vary from the extremes of euphoria 
associated with re-enablement, to despair associated with a renewed realisation of loss. Meanings 
attributed by the user to assistive technology play a decisive role in whether the technology will be 
successfully integrated into an individual’s life (43). Therefore, unless research seeks to understand the 
views and perceptions of potential end users of exoskeleton technology, speculation and uncertainty 
must remain as to whether the technology will be accepted by the population it seeks to enable and 
empower. 
 
McMillen and Söderberg (21) suggest that a device may only be accepted by the person who sees the 
aid as useful for their own purposes. Shah, Robinson (33) suggest that end users quickly discard 
devices that do not fulfil their personal expectations, even though manufacturers and healthcare 
professionals may consider those end users’ requirements met. It is therefore important to acknowledge 
a potential for discrepancy between end users of technology and those responsible for its development 
and prescription, further justifying the relevance and importance of user involvement within design 
processes. 
 
Demain, Burridge (19) used focus groups to ascertain the views of people with stroke, their carers and 
therapists regarding various assistive technology devices for the upper limb. The therapists in their 
purposive sample identified concerns about devices which needed complex adjustment or complex 
programming between patients. Concerns were also raised about devices which would be time 
consuming to clean and difficult to store. For people with stroke and their carers, it was important that 
devices were easy to get on and off and intuitive with respect to positioning and use. Whilst this study 
does not consider exoskeleton technology, the authors define assistive technologies as “electrical or 
mechanical devices designed to help people recover movement”. This definition could readily be 
applied to exoskeleton technology. It is therefore not unlikely that similar concerns might be raised with 
respect to exoskeleton technology by both clinicians responsible for provision and set up of the devices 
and those with neurological impairment who seek to use the devices for functional gain. 
 
It has been suggested that the development of most medical devices arise from either the desire to fulfil 
an unmet need in healthcare diagnosis or treatment, or because a scientific/technological advance 
offers an improved solution to a known problem (46). The latter certainly applies to exoskeleton 
technology. However, Kilgore, Scherer (22) suggest that from the consumer’s perspective, the focus of 
research to restore function ought to be based on the needs and desires of the consumer, not just in 
the scientifically intriguing aspects of a particular technology. 
 
Pioneers of new medical technology are typically scientists or engineers with little experience as device 
users (46). As a consequence, there is a risk that end-products will not meet the needs of the population 
for which they have been developed. The development of exoskeleton technology has caught the 
attention of popular media, who describe the technology as revolutionary. Nevertheless, the current 
literature review has identified a paucity of evidence to suggest that the scientific community responsible 
for development of exoskeleton technology have identified or sought to understand the needs or desires 
of individuals who may ultimately benefit from using it to augment their functional independence. 
 
Conclusion 
Whilst there have been some breakthroughs in exoskeleton technology in recent years, further research 
is needed to identify the aspirations and concerns of potential users of exoskeleton technology in order 
to inform the design and technical development of this innovative technology. 
 
Given the potential that exoskeleton technology has to improve the functional capability and quality of 
life of individuals with neurological impairment it is imperative that their views are sought in relation to 
the ongoing development of this technology. Design teams must understand the difficulties faced by 
potential users in order to ameliorate them with successful designs. 
 
Therefore, further research is needed to identify the aspirations and concerns of potential users of 
exoskeleton technology in order to inform the design and technical development of this innovative 
technology. The authors also wish to encourage research groups that have achieved the 
commercialization of their exoskeleton technology to publish their findings from focus groups 
investigations. 
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Table 1 – Design Specifications of Commercially Available Exoskeletons  
 Weight Battery Life Cost Method of Control Function 
EksoTM  
(13) 
23 Kg Up to 4 
hours 
£52,000 - 
£73,000 
 Battery-powered 
motors   
 The user’s forward 
lateral weight shift 
initiates a step 
 Operated by therapist, 
progressing to 
independent use of 
buttons on crutches or 
Zimmer Frame 
 Medically 
supervised 
standing & 
walking 
ReWalkTM   
(47) 
 
 
 
25Kg 3:15 hours 
of 
continuous 
walking 
£49,500 
(excluding 
£5000 
training 
fees) 
 Computer-based 
control system and 
motion sensors 
 Sensors recognise a 
change in body 
position and trigger 
the desired hip or 
knee movement to 
initiate a step forward 
 Users must have the 
ability to use hands 
and shoulders to 
facilitate walking with 
crutches   
 Standing 
 Ambulation 
indoors & 
outdoors  
 Stair climbing                                                                 
REX® 
(48) 
50Kg 1 hour £80,000  Joystick to control  
 Powered by 
interchangeable 
battery pack  
 No need for crutches 
or walking aids 
 Standing 
 Walking on flat 
ground and 
slopes 
 Stair climbing 
 
 
 
 
 
Table 2: Results from Database Search 
Key Search Terms Results 
Exoskeleton* & User Perspective* 11 
Exoskeleton* & User Experience* 37 
Exoskeleton* & Experience 69 
Robot* & User Perspective*  283 
Robot* & User Experience*  94 
Exoskeleton* & Qualitative & Rehab* 31 
Robot* & Qualitative & Rehab* 250 
Technology & Qualitative & Rehab* and (spinal 
cord injury) 
40 
Technology & Qualitative & Rehab* and (stroke) 74 
Technology & Qualitative & Rehab* and (neuro*) 23 
Total Articles 912 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Flow Diagram Detailing Literature Review Process 
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